CME · 10-Q · 2026Q3 · Full report

Liquidity and Debt Position

CME GROUP INC. · 2026-10-23 · Importance 15 · Surprise 46 · Matches filing data

Cash and cash equivalents, excluding restricted cash, totaled $2.2 billion at September 30, 2026, down from $4.4 billion at December 31, 2025. Outstanding fixed-rate notes had aggregate par value of $3.45 billion, with maturities from June 2028 through June 2048; no borrowings were outstanding under the $2.3 billion corporate revolving facility or the $7.0 billion clearing-house secured facility. The company had approximately $2.3 billion of excess corporate borrowing capacity and $10.2 billion of guaranty fund contributions available to collateralize the clearing-house facility. S&P rated the company AA- and Moody’s rated it Aa3, both with stable outlooks; the company reported compliance with all debt-facility covenants.

Key facts

Impact estimates

metricdirectionstageexpectedbasis
cashnegativerealized-1.1%CME Group's cash and cash equivalents, excluding restricted cash, were $2.2 billion at September 30, 2026, compared with $4.4 billion at…